newsfilter
← Latest News
GlobeNewswire·

Small Pharma Reports Fiscal First Quarter 2023 Highlights

Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a biotechnology